ALL vs SER · P/E 4.9, $56.89B cap vs rev $56.0K
The Allstate Corporation (ALL) versus Serina Therapeutics Inc (SER) — a side-by-side from cached financials, not a winner call.
The Allstate Corporation (ALL) is a insurance - property & casualty company listed on US.
Serina Therapeutics Inc (SER) is a biotechnology company listed on AMEX.
ALL does not have a complete income-statement cache yet.
Latest reported SER revenue for 2024-12-31 was $56.0K. Net income was -$11.2M. Revenue was down 98.2% from 2023-12-31 to 2024-12-31. SER currently screens at market cap $29.7M.
ALL currently screens at market cap $56.89B and trailing P/E 4.9. SER currently screens at market cap $29.7M.
Not investment advice. Open the ALL and SER stock pages for the full models.
Not investment advice.